Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial-Reference-Cited by-同舟云学术

Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial

Published:2023-10-19 Issue:1 Volume:63 Page:95-105
ISSN:1436-6207
Container-title:European Journal of Nutrition
language:en
Short-container-title:Eur J Nutr

Author:

Sangouni Abbas Ali,Nadjarzadeh Azadeh,Rohani Fatemeh Sadat,Sharuni Fatemeh,Zare Zahra,Rahimpour Shahab,Hojjat Hashem,Hosseinzadeh Mahdieh^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://link.springer.com/content/pdf/10.1007/s00394-023-03221-w.pdf

Reference57 articles.

1. Eslam M, Sanyal AJ, George J et al (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7):1999-2014.e1

2. Araújo AR, Rosso N, Bedogni G et al (2018) Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future. Liver Int 38(Suppl 1):47–51

3. Zoller H, Tilg H (2016) Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism 65(8):1151–1160

4. Kim CH, Younossi ZM (2008) Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med 75(10):721–728

5. Sangouni AA, Ghavamzadeh S (2019) A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. Diabetes Metab Syndr Clin Res Rev 13(5):2917–2922

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese-modified MIND Diet and subjective well‑being in adults aged 60 years or older in China: a national community-based cohort study;European Journal of Nutrition;2024-09-04

2. Identifying metabolic dysfunction-associated steatotic liver disease in patients with hypertension and pre-hypertension: An interpretable machine learning approach;DIGITAL HEALTH;2024-01